Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antiviral Drug Discovery for the Treatment of COVID-19 Infections
Teresa I. Ng, Ivan Correia, Jane Seagal, et al.
Viruses (2022) Vol. 14, Iss. 5, pp. 961-961
Open Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

Introduction to Traditional Medicine and Their Role in Prevention and Treatment of Emerging and Re-Emerging Diseases
Syed A. A. Rizvi, George P Einstein, Orien L. Tulp, et al.
Biomolecules (2022) Vol. 12, Iss. 10, pp. 1442-1442
Open Access | Times Cited: 71
A yeast-based system to study SARS-CoV-2 Mpro structure and to identify nirmatrelvir resistant mutations
Jin Ou, Eric M. Lewandowski, Yanmei Hu, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 8, pp. e1011592-e1011592
Open Access | Times Cited: 25
Water–glycan interactions drive the SARS-CoV-2 spike dynamics: insights into glycan-gate control and camouflage mechanisms
Marharyta Blazhynska, Louis Lagardère, Chengwen Liu, et al.
Chemical Science (2024) Vol. 15, Iss. 35, pp. 14177-14187
Open Access | Times Cited: 9
A population-scale temporal case–control evaluation of COVID-19 disease phenotype and related outcome rates in patients with cancer in England (UKCCP)
Thomas Starkey, Maria C. Ionescu, Michaël Tilby, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 17
On the origins of SARS-CoV-2 main protease inhibitors
Yves L. Janin
RSC Medicinal Chemistry (2023) Vol. 15, Iss. 1, pp. 81-118
Closed Access | Times Cited: 17
Bridging healthcare gaps: a scoping review on the role of artificial intelligence, deep learning, and large language models in alleviating problems in medical deserts
Zdeslav Strika, Karlo Petković, Robert Likić, et al.
Postgraduate Medical Journal (2024)
Closed Access | Times Cited: 8
Development of Novel Antivrial Agents That Induce the Degradation of the Main Protease of Human-infecting Coronaviruses
Shuihong Cheng, Yong Feng, Wei Li, et al.
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116629-116629
Closed Access | Times Cited: 6
A first-in-human phase 1 study of simnotrelvir, a 3CL-like protease inhibitor for treatment of COVID-19, in healthy adult subjects
Xin‐Mei Yang, Yang Yang, Bu‐Fan Yao, et al.
European Journal of Pharmaceutical Sciences (2023) Vol. 191, pp. 106598-106598
Open Access | Times Cited: 15
SARS-CoV-2 Specific Nanobodies Neutralize Different Variants of Concern and Reduce Virus Load in the Brain of h-ACE2 Transgenic Mice
María F. Pavan, Marina Bok, Rafael Betanzos San Juan, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 185-185
Open Access | Times Cited: 5
Ubiquitin Ligase Parkin Regulates the Stability of SARS-CoV-2 Main Protease and Suppresses Viral Replication
Li Zhou, Ruochuan Liu, Heather Pathak, et al.
ACS Infectious Diseases (2024) Vol. 10, Iss. 3, pp. 879-889
Open Access | Times Cited: 5
Efficacy and safety evaluation of Azvudine in the prospective treatment of COVID-19 based on four phase III clinical trials
Ke‐Wei Zhu
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 12
Application of Established Computational Techniques to Identify Potential SARS-CoV-2 Nsp14-MTase Inhibitors in Low Data Regimes
AkshatKumar Nigam, Matthew F. D. Hurley, Fengling Li, et al.
Digital Discovery (2024) Vol. 3, Iss. 7, pp. 1327-1341
Open Access | Times Cited: 4
Structure–Activity Relationship of Ciprofloxacin towards S-Spike Protein of SARS-CoV-2: Synthesis and In-Silico Evaluation
Sahil Kumar, Papiya Dey, Arup Kumar Pathak, et al.
Journal of Chemical Information and Modeling (2025)
Closed Access
Azadirachta Indica Phytoconstituents as Novel Inhibitors for Main Proteases of COVID-19: Molecular Dynamics and Simulation Study
Ubaida Hussain, Fatima Gillani, Laiba Gull, et al.
Indus journal of bioscience research. (2025) Vol. 3, Iss. 1, pp. 74-84
Closed Access
In Silico Binding Role of Flavonoids as SARS-CoV-2 Main Protease (Mpro) Inhibitors: A Dataset of Molecular Docking Simulation-Based High-Throughput Virtual Screening (HTVS)
Mariyam Eema, Vasudeva Rao Avupati
Data in Brief (2025), pp. 111308-111308
Open Access
Advancements in the development of antivirals against SARS-Coronavirus
Mrityunjay Kumar, Mirza Sarwar Baig, Kanchan Bhardwaj
Frontiers in Cellular and Infection Microbiology (2025) Vol. 15
Open Access
Bioactives From Brown Algae: Antioxidant, Anti‐Inflammatory, Anticancer, and Antimicrobial Potential
Irvin Fonseca‐Barahona, Kaveh Shahbaz, Saeid Baroutian
ChemBioEng Reviews (2025)
Open Access
Discovery of SARS-CoV-2 Nsp14-Methyltransferase (MTase) Inhibitors by Harnessing Scaffold-Centric Exploration of the Ultra Large Chemical Space
Sourav Pal, Quinlin M. Hanson, Sarah C. Ogden, et al.
ACS Pharmacology & Translational Science (2025)
Closed Access
COVID-19 Rebound After Paxlovid Treatment: A Case Series and Review of Literature
Shatha Alshanqeeti, Ashish Bhargava
Cureus (2022)
Open Access | Times Cited: 18
Biochemical Screening of Phytochemicals and Identification of Scopoletin as a Potential Inhibitor of SARS-CoV-2 Mpro, Revealing Its Biophysical Impact on Structural Stability
Sarika Bano, Jyotishna Singh, Zainy Zehra, et al.
Viruses (2025) Vol. 17, Iss. 3, pp. 402-402
Open Access
Efficient CRISPR-Cas13d-Based Antiviral Strategy to Combat SARS-CoV-2
Mouraya Hussein, Zaria Andrade dos Ramos, Monique Vink, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 686-686
Open Access | Times Cited: 8
Discussing Artificial Intelligence's Role in Combatting the COVID-19 Pandemic: A Review

Mesopotamian Journal of Artificial Intelligence in Healthcare (2023), pp. 7-14
Open Access | Times Cited: 8
Viral Factors in Modulation of Host Immune Response: A Route to Novel Antiviral Agents and New Therapeutic Approaches
Olga Tarasova, Anthi Petrou, Sergey M. Ivanov, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9408-9408
Open Access | Times Cited: 3
SARS-CoV-2 main protease (3CLpro) interaction with acyclovir antiviral drug/methyl-β-cyclodextrin complex: Physiochemical characterization and molecular docking
Sonaimuthu Mohandoss, Ramaraj Sukanya, Sivarasan Ganesan, et al.
Journal of Molecular Liquids (2022) Vol. 366, pp. 120292-120292
Open Access | Times Cited: 13
Leveraging SARS-CoV-2 Main Protease (Mpro) for COVID-19 Mitigation with Selenium-Based Inhibitors
Viviana De Luca, Andrea Angeli, Alessio Nocentini, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 971-971
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top